BiologyWorks k(now)™ COVID-19 Clinical Trial Matches 99.1% Accuracy to RT-PCR Tests
BiologyWorks k(now)™ Handheld Molecular Testing Device Among the Most Accurate for COVID-19 LOS ANGELES--(BUSINESS WIRE)--$COVID #cemark--BiologyWorks™, Inc., a digital healthcare platform company, today announced that a substantive clinical trial of its handheld, reusable molecular test for COVID-19 matched 99.1% accuracy to laboratory RT-PCR tests. The independent clinical trial, conducted by…